BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37930844)

  • 1. Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada.
    Vekic N; Armstrong-Price D; Woodall K
    J Anal Toxicol; 2023 Nov; 47(8):762-769. PubMed ID: 37930844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases.
    Papsun DM; Krotulski AJ; Homan J; Temporal KDH; Logan BK
    J Anal Toxicol; 2021 Mar; 45(3):226-232. PubMed ID: 32542312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoral blood concentrations of flualprazolam in 33 postmortem cases.
    Kriikku P; Rasanen I; Ojanperä I; Thelander G; Kronstrand R; Vikingsson S
    Forensic Sci Int; 2020 Feb; 307():110101. PubMed ID: 31865266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam.
    Canfield JR; Kisor DF; Sprague JE
    Toxicol Appl Pharmacol; 2023 Apr; 465():116459. PubMed ID: 36907383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driving Impairment Cases Involving Flualprazolam.
    Youso KB; Osawa KA; Divine ML; Rohrig TP
    J Anal Toxicol; 2022 Aug; 46(7):e191-e195. PubMed ID: 35404449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving Impairment Cases Involving Etizolam and Flubromazolam.
    Rohrig TP; Osawa KA; Baird TR; Youso KB
    J Anal Toxicol; 2021 Feb; 45(1):93-98. PubMed ID: 32399568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
    Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
    J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flualprazolam distribution in postmortem samples.
    Ha HH; Mata DC
    J Forensic Sci; 2022 Jan; 67(1):297-308. PubMed ID: 34585411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Two-Year Evaluation of Flualprazolam Concentrations in Orange County Drivers: Effects on Driving and Field Sobriety Test Performance.
    Manaloto FR; Meneses VM; Mata DC
    J Anal Toxicol; 2023 Jan; 46(9):1038-1044. PubMed ID: 35244711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues.
    Giorgetti A; Sommer MJ; Wilde M; Perdekamp MG; Auwärter V
    Forensic Toxicol; 2022 Jan; 40(1):180-188. PubMed ID: 36454486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine.
    Huppertz LM; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):206-211. PubMed ID: 28378533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G; Tuv SS; Karinen R
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
    Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
    Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019-2020).
    Watts C; Martin TL
    J Anal Toxicol; 2022 Aug; 46(7):719-725. PubMed ID: 34570874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flubromazolam: Detection in five post-mortem cases.
    Abdul K; Hikin L; Smith P; Kurimbokus H; Ashong E; Couchman L; Morley SR
    Med Sci Law; 2020 Oct; 60(4):266-269. PubMed ID: 32838670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
    Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
    Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021.
    Papsun DM; Chan-Hosokawa A; Lamb ME; Logan B
    J Anal Toxicol; 2023 Nov; 47(8):668-679. PubMed ID: 37338191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom.
    Haden M; Cashman J; Ketchin A; Macfarlane R; Issa S; Eddleston M; Hines S; Hudson S; Hill SL; Thomas SHL
    Clin Toxicol (Phila); 2022 Jan; 60(1):33-37. PubMed ID: 34080515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flualprazolam: Report of an Outbreak of a New Psychoactive Substance in Adolescents.
    Blumenberg A; Hughes A; Reckers A; Ellison R; Gerona R
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32581001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
    Mei V; Concheiro M; Pardi J; Cooper G
    J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.